Regulatory Policy Changes and Mifepristone Access Through Pharmacies in Australia - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

How Regulatory Policy Shifts Affect Pharmacy Access to Mifepristone in Australia

  • By

  • Kristina Edvardsson

  • Laura Schummers

  • Jessica E. Moulton

  • Xia Li

  • Lucy Cheng

  • Danielle Mazza

  • Philip Goldstone

  • Daniel Grossman

  • October 7, 2026

Share

  • 1

    Australia approved mifepristone-misoprostol in 2012 with restrictions on prescribing and dispensing.

  • 2

    On August 1, 2023, the TGA removed prescribing and dispensing restrictions, allowing any pharmacist to dispense the medication.

  • 3

    The revised framework also broadened prescribing eligibility to appropriately qualified and trained practitioners, including nurse practitioners and endorsed midwives.

  • 4

    The study used monthly sales records from Australia’s sole distributor to community and hospital outpatient pharmacies for 24 months before and after deregulation.

  • 5

    The study examined whether deregulation was followed by more pharmacies ordering mifepristone-misoprostol and a broader geographic distribution of those pharmacies.

Original Source(s)

Regulatory Policy Changes and Mifepristone Access Through Pharmacies in Australia

  • by Kristina Edvardsson, Laura Schummers, Jessica E. Moulton, Xia Li, Lucy Cheng, Danielle Mazza, Philip Goldstone, Daniel Grossman

  • October 7, 2026

Related Content

Medicaid Enrollees’ Access to Contraceptive Services at Community Health Centers

Clitoral reconstruction may preserve sexual function

Nearly 90% of patients reported preserved clitoral sensation and the ability to achieve orgasm following reconstruction.

Identifying Differences in Autism Factors Using Maternal vs Child Race and Ethnicity